相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis
Hao Liu et al.
CELL DEATH AND DIFFERENTIATION (2020)
Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study
Sixten Harborg et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Association Between Statin Use and Prognosis of Breast Cancer: A Meta-Analysis of Cohort Studies
Hui Lv et al.
FRONTIERS IN ONCOLOGY (2020)
Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome
Sidse Ehmsen et al.
CELL REPORTS (2019)
Statin use and breast cancer survival - a Swedish nationwide study
Signe Borgquist et al.
BMC CANCER (2019)
Statins: a role in breast cancer therapy?
S. Borgquist et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states
Andrew Sulaiman et al.
MOLECULAR ONCOLOGY (2018)
Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer
Louise Emilsson et al.
JAMA ONCOLOGY (2018)
Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer
Xinhui Kou et al.
CANCER SCIENCE (2018)
Statins attenuate outgrowth of breast cancer metastases
Colin H. Beckwitt et al.
BRITISH JOURNAL OF CANCER (2018)
Statin drugs to reduce breast cancer recurrence and mortality
Colin H. Beckwitt et al.
BREAST CANCER RESEARCH (2018)
Triple-negative breast cancer: is there a treatment on the horizon?
Hui Yao et al.
ONCOTARGET (2017)
Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study
Signe Borgquist et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Mevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cells
Zhaohu Lin et al.
Oncotarget (2017)
Impact of Statin Use on Outcomes in Triple Negative Breast Cancer
Simona F. Shaitelman et al.
JOURNAL OF CANCER (2017)
Effect of statins on breast cancer recurrence and mortality: a review
Renae D. Van Wyhe et al.
BREAST CANCER-TARGETS AND THERAPY (2017)
Statin use and breast cancer survival: a nationwide cohort study in Scotland
Una C. Mc Menamin et al.
BMC CANCER (2016)
Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis
Sashidhar Manthravadi et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Rasha Khatib et al.
LANCET (2016)
Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency
Hae Hyun Jung et al.
SCIENTIFIC REPORTS (2016)
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a
Adam R. Wolfe et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Statin Use After Diagnosis of Breast Cancer and Survival A Population-based Cohort Study
Chris R. Cardwell et al.
EPIDEMIOLOGY (2015)
Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland
Teemu J. Murtola et al.
PLOS ONE (2014)
Simvastatin Radiosensitizes Differentiated and Stem-Like Breast Cancer Cell Lines and Is Associated With Improved Local Control in Inflammatory Breast Cancer Patients Treated With Postmastectomy Radiation
Lara Lacerda et al.
STEM CELLS TRANSLATIONAL MEDICINE (2014)
Triple-Negative Breast Cancer and the Need for New Therapeutic Targets
Olav Engebraaten et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Statin induces inhibition of triple negative breast cancer (TNBC) cells via PI3K pathway
Yeon Hee Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
Olof Bjarnadottir et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol
Archana Gopalan et al.
CANCER LETTERS (2013)
Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort
Stefan Nickels et al.
PLOS ONE (2013)
Paracrine Wnt signaling both promotes and inhibits human breast tumor growth
Jennifer L. Green et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
Goodarz Danaei et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression
Carmine Spampanato et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Accuracy of hospital morbidity data and the performance of comorbidity scores as predictors of mortality
George Mnatzaganian et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
Justin M. Balko et al.
NATURE MEDICINE (2012)
Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study
Bart S. Ferket et al.
PLOS MEDICINE (2012)
Simvastatin Prevents Skeletal Metastasis of Breast Cancer by an Antagonistic Interplay between p53 and CD44
Chandi Charan Mandal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
Thomas P. Ahern et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
Elisabeth R. Garwood et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth
Nayana Ghosh-Choudhury et al.
CELLULAR SIGNALLING (2010)
Statin use and cancer risk: a comprehensive review
Denise M. Boudreau et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Statins and Breast Cancer: May Matrix Metalloproteinase be the Missing Link
Ferdinando Mannello et al.
CANCER INVESTIGATION (2009)
Brick by brick: metabolism and tumor cell growth
Ralph J. DeBerardinis et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
Marilyn L. Kwan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Breast cancer progression: insights into multifaceted matrix metalloproteinases
Vincent Chabottaux et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Development of a comorbidity index using physician claims data
CN Klabunde et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
分享论文
